What Happened?
, -based SpyBiotech Appointed Keith Dewedoff as Chief Financial Officer
About the Company
SpyBiotech is a UK-based company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases. SpyBiotech was spun out of the University of Oxford in 2017. Its proprietary protein superglue technology binds antigens to vaccine delivery platforms in a way which minimizes delivery risk and enhances immunogenicity and efficacy. The companys current lead candidate is against human cytomegalovirus (HCMV), with clinical studies planned for this year.
About the Person
Keith Dewedoff is Chief Financial Officer at SpyBiotech. Previously, Keith held various senior HR leadership roles in the industry.
Info Source
News
Short Profile